 The VIAjectTM 06J study is the efficacy and safety study for insulin VIAjectTM to demonstrate equivalent blood glucose control in patients with type 1 diabetes mellitus with insulin and regular human insulin as prandial insulin and to demonstrate an equivalent safety profile for VIAjectTM in comparison to human insulin 